<DOC>
	<DOCNO>NCT00210548</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety 3 dos paliperidone palmitate treat subject schizophrenia .</brief_summary>
	<brief_title>A Study Evaluate Effectiveness Safety 3 Doses Paliperidone Palmitate Treating Subjects With Schizophrenia</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , parallel-group , multicenter , dose-response study patient Diagnostic Statistical Manual Mental Disorders , 4th edition ( DSM IV ) diagnosis schizophrenia . The duration study approximately 14 week , include screen period 1 week 13-week double-blind treatment period . Efficacy safety evaluate periodically throughout study . Samples pharmacokinetic evaluation collect designated time point , blood sample collect baseline ( start double-blind treatment ) optional pharmacogenomics ( genetics ) analysis . The hypothesis 3 fixed dos paliperidone efficacious placebo treat subject schizophrenia . The effectiveness measure primarily change Positive Negative Syndrome Scale Schizophrenia ( PANSS ) , secondarily , investigator 's Clinical Global Impression Severity ( CGI-S ) investigator 's evaluation patient Personal Social Performance ( PSP ) Scale . Four injection paliperidone palmitate 50 , 100 , 150 milligram equivalent administer gluteal muscle ( buttock ) . Injections give Days 1 , 8 , 36 , 64 double-blind treatment period study .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<criteria>A DSMIV diagnosis schizophrenia ( disorganize , catatonic , paranoid , residual , undifferentiated type ) least 1 year screen evaluation total PANSS score 70 120 screening baseline ( pretreatment ) evaluation body mass index ( BMI [ weight ( kilogram ) ] / [ height ( meter ) ] ² ) 17.0 kg/m² A primary active DSMIV Axis I diagnosis schizophrenia decrease 25 % total PANSS score screen baseline evaluation DSMIV diagnosis active substance dependence within 3 month screen evaluation history treatment resistance define failure respond 2 adequate trial different antipsychotic medication woman pregnant , breastfeeding , plan become pregnant study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>intramuscular injection</keyword>
	<keyword>antipsychotic agent</keyword>
	<keyword>dementia praecox</keyword>
	<keyword>paliperidone palmitate</keyword>
	<keyword>mental disorder</keyword>
	<keyword>PANSS .</keyword>
</DOC>